HMR1964A/3011
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HMR1964A/3011, covering 2008-01-09 to 2008-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Extension to Study HMR1964A/3011 in Belgium [Phase 4]